2632-2498

Neuro-Oncology Advances

Oxford University Press

View prefix report (10.1093)

Health Score

0 Good

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Attach ORCID iDs across 2521 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

High impact2521 DOIs
2

Deposit reference lists for 2336 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

High impact2336 DOIs
3

Add abstracts to 148 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Low impact148 DOIs

DOIs for this ISSN

Showing the top 5 of 3708 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 LPTO-02. INTRATHECAL (IT) TRASTUZUMAB (T) FOR THE TREATMENT… (10.1093/noajnl/vdz014.025)
References ORCID
50.00 9
2 Imaging findings following regorafenib in malignant gliomas:… (10.1093/noajnl/vdz038)
Abstract ORCID
50.00 9
3 Proceedings of the Comprehensive Oncology Network Evaluating… (10.1093/noajnl/vdz048)
ORCID License
47.71 8
4 Current status of PET imaging in neuro-oncology (10.1093/noajnl/vdz010)
ORCID
45.97 68
5 Integrated models incorporating radiologic and radiomic feat… (10.1093/noajnl/vdz011)
ORCID
45.65 66
6 Clinical trial design in neurofibromatosis type 1 as a model… (10.1093/noajnl/vdaa017)
ORCID License
45.15 7
7 Entrectinib demonstrates prolonged efficacy in an adult case… (10.1093/noajnl/vdac046)
Abstract ORCID
45.15 7
8 The current state of glioma data registries (10.1093/noajnl/vdac099)
ORCID License
45.15 7
9 Intracranial mesenchymal tumor, FET::CREB fusion-positive in… (10.1093/noajnl/vdad026)
Abstract ORCID
45.15 7
10 Corrigendum to: Clinical utility of whole-genome DNA methyla… (10.1093/noajnl/vdad114)
Abstract References ORCID
45.15 3
11 Brief CommunicationCirculating tumor DNA is present in the m… (10.1093/noajnl/vdaa068)
Abstract ORCID
42.25 6
12 Bone metastases in an adult patient with diffuse midline gli… (10.1093/noajnl/vdaa156)
Abstract ORCID
42.25 6
13 Targeting protein arginine methyltransferase 5 sensitizes gl… (10.1093/noajnl/vdac095)
ORCID License
42.25 6
14 Molecular profiles and immunomodulatory activities of gliobl… (10.1093/noajnl/vdaa056)
ORCID
41.33 44
15 A phase Ib/IIa trial of 9 repurposed drugs combined with tem… (10.1093/noajnl/vdab075)
ORCID
41.09 43
16 Epidemiology of synchronous brain metastases (10.1093/noajnl/vdaa041)
ORCID
40.58 41
17 Laser interstitial thermal therapy (10.1093/noajnl/vdz035)
ORCID
40.58 41
18 Nivolumab plus radiotherapy with or without temozolomide in… (10.1093/noajnl/vdac025)
ORCID
39.78 38
19 RADI-12. Deep learning for automatic detection and contourin… (10.1093/noajnl/vdab071.082)
References ORCID
38.91 5
20 Optimizing management of the elderly patient with glioblasto… (10.1093/noajnl/vdac052)
ORCID License
38.91 5
21 TIPS-17 A FIRST-IN-HUMAN FEASIBILITY STUDY TO EVALUATE THE S… (10.1093/noajnl/vdad070.147)
References ORCID
38.91 5
22 Sex differences in glioblastoma response to treatment: Impac… (10.1093/noajnl/vdae031)
Abstract License
38.91 5
23 Long-term survivors of glioblastoma are a unique group of pa… (10.1093/noajnl/vdz056)
Abstract ORCID
38.91 5
24 Tumor-associated macrophage infiltration in meningioma (10.1093/noajnl/vdz018)
ORCID
38.60 34
25 Rapid intraoperative molecular genetic classification of gli… (10.1093/noajnl/vdz008)
ORCID
37.96 32
26 Suicide gene therapy for the treatment of high-grade glioma:… (10.1093/noajnl/vdaa013)
ORCID
37.28 30
27 Comparison of epidemiology, treatments, and outcomes in pedi… (10.1093/noajnl/vdaa019)
ORCID
36.93 29
28 Receptor tyrosine kinases as druggable targets in glioblasto… (10.1093/noajnl/vdab133)
ORCID
36.93 29
29 Constitutional mismatch repair deficiency–associated brain t… (10.1093/noajnl/vdz033)
ORCID
36.93 29
30 The promise of DNA damage response inhibitors for the treatm… (10.1093/noajnl/vdab015)
ORCID
36.56 28
31 Multidisciplinary patient-centered management of brain metas… (10.1093/noajnl/vdaa034)
ORCID
36.18 27
32 T2/FLAIR-mismatch sign for noninvasive detection of IDH-muta… (10.1093/noajnl/vdaa004)
ORCID
35.78 26
33 A novel fully automated MRI-based deep-learning method for c… (10.1093/noajnl/vdaa066)
ORCID
35.78 26
34 Corrigendum to: Generation of chromosome 1p/19q co-deletion… (10.1093/noajnl/vdad005)
Abstract References ORCID
35.78 2
35 Low-dose oncolytic adenovirus therapy overcomes tumor-induce… (10.1093/noajnl/vdaa011)
ORCID
35.37 25
36 Epidemiology of vestibular schwannoma in the United States,… (10.1093/noajnl/vdaa135)
ORCID
35.37 25
37 The glutamine antagonist prodrug JHU-083 slows malignant gli… (10.1093/noajnl/vdaa149)
ORCID
35.37 25
38 Radiation treatment of benign tumors in NF2-related-schwanno… (10.1093/noajnl/vdad025)
ORCID
35.37 25
39 cIMPACT-NOW update 9: Recommendations on utilization of geno… (10.1093/noajnl/vdae228)
License
35.37 25
40 Optimization of deep learning methods for visualization of t… (10.1093/noajnl/vdaa110)
ORCID
34.95 24
41 Artificial Intelligence, Radiomics, and Deep Learning in Neu… (10.1093/noajnl/vdaa179)
Abstract ORCID
34.95 4
42 Health-related quality of life in meningioma (10.1093/noajnl/vdab089)
ORCID
34.95 24
43 Management of brain metastases in lung cancer: evolving role… (10.1093/noajnl/vdab106)
ORCID
34.95 24
44 Generation of immunocompetent syngeneic allograft mouse mode… (10.1093/noajnl/vdac079)
ORCID
34.95 24
45 Label-free multiphoton imaging allows brain tumor recognitio… (10.1093/noajnl/vdaa035)
ORCID
34.51 23
46 Mebendazole and temozolomide in patients with newly diagnose… (10.1093/noajnl/vdaa154)
ORCID
34.51 23
47 Phase I trial of intranasal NEO100, highly purified perillyl… (10.1093/noajnl/vdab005)
ORCID
34.51 23
48 Primary CNS lymphoma commonly expresses immune response biom… (10.1093/noajnl/vdaa018)
ORCID
33.56 21
49 Identification of subsets of IDH-mutant glioblastomas with d… (10.1093/noajnl/vdz015)
ORCID
33.56 21
50 Multi-institutional noninvasive in vivo characterization of… (10.1093/noajnl/vdaa128)
ORCID
33.06 20